Efe, C. Et Al. 2022. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis. Journal of Autoimmunity , vol.132 .

Efe, C., Taşçılar, K., Gerussi, A., Bolis, F., Lammert, C., Ebik, B., ... Stättermayer, A. F.(2022). SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis. Journal of Autoimmunity , vol.132.

Efe, Cumali Et Al. "SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis," Journal of Autoimmunity , vol.132, 2022

Efe, Cumali Et Al. "SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis." Journal of Autoimmunity , vol.132, 2022

Efe, C. Et Al. (2022) . "SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis." Journal of Autoimmunity , vol.132.

@article{article, author={Cumali Efe Et Al. }, title={SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis}, journal={Journal of Autoimmunity}, year=2022}